156 related articles for article (PubMed ID: 5139056)
1. [Evaluation of skin tests at sites of administration of Synalar ointment under occlusive dressings].
Lańcucki J; Borkowski MS; Samos J; Mika T
Przegl Dermatol; 1971; 58(5):575-9. PubMed ID: 5139056
[No Abstract] [Full Text] [Related]
2. [Treatment of 2d degree burns with Oxycort-aerosol and Synalar ointment under occlusive dressings].
Lańcucki J; Wysocki C; Ratka P; Ogonowski E
Przegl Dermatol; 1973; 60(4):537-42. PubMed ID: 4755920
[No Abstract] [Full Text] [Related]
3. [Treatment of psoriasis with Synalar ointment].
Chowaniec O
Przegl Dermatol; 1973; 60(2):234-8. PubMed ID: 4791679
[No Abstract] [Full Text] [Related]
4. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
Burdick KH
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631
[No Abstract] [Full Text] [Related]
5. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Szadurski J; Renz F; Gasser D
Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
[TBL] [Abstract][Full Text] [Related]
6. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids.
Kalkoff KW
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633
[No Abstract] [Full Text] [Related]
7. [On the effect of fluocinolone acetonide on the DNA synthesis in the epidermis].
Kalkoff KW; Born W
Klin Wochenschr; 1965 Dec; 43(24):1335-7. PubMed ID: 5334373
[No Abstract] [Full Text] [Related]
8. [Epidermal DNA synthesis under occlusive dressings in the tritium-thymidine autoardiogram].
Born W
Z Haut Geschlechtskr; 1969 May; 44(9):305-10. PubMed ID: 5772389
[No Abstract] [Full Text] [Related]
9. [Topical corticosteroid treatment of erythema caused by ultraviolet irradiation].
Nater JP; Bleumink E
Ned Tijdschr Geneeskd; 1979 May; 123(20):825-7. PubMed ID: 375107
[No Abstract] [Full Text] [Related]
10. [Complications in the course of the treatment of rosacea with fluocinolone acetonide (Synalar ointment].
Mazurkiewicz W; Dabrowska H; Wnorowski J; Chadzynska M
Przegl Dermatol; 1971; 58(3):297-305. PubMed ID: 4257400
[No Abstract] [Full Text] [Related]
11. [Spectacular action of fluocinolone acetonide occlusive dressings in 3 cases of generalized lichen planus].
Duntze F; Tupin J
Bull Soc Fr Dermatol Syphiligr; 1968; 75(2):202-3. PubMed ID: 5677899
[No Abstract] [Full Text] [Related]
12. Photosensitivity following treatment with occlusive dressings.
Cattano AN
Arch Dermatol; 1970 Sep; 102(3):276-9. PubMed ID: 5456017
[No Abstract] [Full Text] [Related]
13. Corticosteroid ointments: comparison by two human bioassays.
Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
[No Abstract] [Full Text] [Related]
14. [On the effectiveness of highly concentrated fluocinolone acetonide cream in various skin diseases].
Gebhardt R; Holzmann H
Med Welt; 1969 Mar; 9():484-8. PubMed ID: 5771355
[No Abstract] [Full Text] [Related]
15. Corticosteroid bioavailability assays. Correlation with a clinical study.
Burdick KH
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):19-23. PubMed ID: 5291630
[No Abstract] [Full Text] [Related]
16. Effect of fluocinolone acetonide cream on human skin blood flow.
Chimoskey JE; Holloway GA; Flanagan WJ
J Invest Dermatol; 1975 Aug; 65(2):241-3. PubMed ID: 1151118
[TBL] [Abstract][Full Text] [Related]
17. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
Coleman GL; Kanfer I; Haigh JM
Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
[TBL] [Abstract][Full Text] [Related]
18. [Use of 1 Synalar cream in some dermatological diseases].
Mazurkiewicz W; Chadzyńska M
Przegl Dermatol; 1971; 58(5):609-14. PubMed ID: 5139061
[No Abstract] [Full Text] [Related]
19. Determination of plasma cortisol in patients treated with fluocinonide cream with either open or occlusive application.
Pozzo G; Prandini BD
Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):40-2. PubMed ID: 5291632
[No Abstract] [Full Text] [Related]
20. The psoriasis bio-assay for topical corticosteroid activity.
Dumas KJ; Scholtz JR
Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
